VivoSeq
Other

Beta-Cell Function

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Beta-cell Function is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

13/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

8

clinical trials

Completed5 · 63%
Not yet recruiting1 · 13%
Withdrawn1 · 13%
Unknown status1 · 13%

Clinical Trials

Trial Activity

8 trials

Effects of Cofrogliptin on Beta-Cell Function in LADA Patients
Not yet recruiting·SSecond Xiangya Hospital of Central South University·N/A·NCT07460336·84 enrolled
Effect of Dietary Glycemic Index on Beta-cell Function
Completed·SSeattle Institute for Biomedical and Clinical Research·N/A·NCT01386645·56 enrolled
Intervention to Preserve Beta-Cell Function in GAD Ab-Positive Diabetes
Completed·TTokyo Study Group·N/A·NCT00232375·42 enrolled
Beta-Cell Function After Near-Normalisation of Blood Glucose
Completed·HHvidovre University Hospital·N/A·NCT00612950·8 enrolled
Beta-Cell Function of Insulin Glargine Compared to Neutral Protamine Hagedorn (NPH) Insuline and to Insulin Detemir in Combination With Metformin
Completed·Iikfe-CRO GmbH·Phase 4·NCT00941148·30 enrolled
Beta-Cell Function and Sitagliptin Trial (BEST)
Completed·SSamuel Lunenfeld Research Institute, Mount Sinai Hospital·Phase 2·NCT00420511·21 enrolled
IL-1RA, Acute Exercise, and Beta-cell Function
Withdrawn·—·N/A·NCT02310009
Effect of Alogliptin/Pioglitazone on the Preservation of Long-term Beta-cell Function
Unknown status·KKyunghee University Medical Center·Phase 4·NCT02823808·96 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)